Literature DB >> 11186160

Learning and memory in bipolar and unipolar major depression: effects of aging.

T Burt1, J Prudic, S Peyser, J Clark, H A Sackeim.   

Abstract

OBJECTIVE: The goal of this study was to examine the effects of aging on neuropsychological functions in bipolar and unipolar major depression.
BACKGROUND: Earlier studies suggested that neurocognitive deficits in mood disorder patients correlate with duration and severity of illness and also that bipolar disorder has a more virulent course than unipolar disorder. We hypothesized that elderly patients with bipolar disorder will demonstrate greater neurocognitive dysfunction than young patients with bipolar disorder and elderly patients with unipolar disorder.
METHOD: A battery of tests of general intelligence and learning and memory was administered to 79 inpatients with major depression referred for electroconvulsive therapy. With patients 60 years of age and older defined as elderly, there were 29 young and 24 elderly unipolar patients and 13 young and 13 elderly bipolar patients.
RESULTS: Unipolar and bipolar patients did not differ in measures of general intelligence or global cognitive status. Generally, across tests of memory, young bipolar patients exhibited the best performance and elderly bipolar patients exhibited the poorest performance.
CONCLUSIONS: The results suggest that over the course of their illness, patients with bipolar disorder experience greater deterioration in memory functions than patients with unipolar disorder. Longitudinal studies are required to support the preliminary findings of this cross-sectional study.

Entities:  

Mesh:

Year:  2000        PMID: 11186160

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  9 in total

1.  Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.

Authors:  Colin A Depp; David J Moore; David Sitzer; Barton W Palmer; Lisa T Eyler; Scott Roesch; Barry D Lebowitz; Dilip V Jeste
Journal:  J Affect Disord       Date:  2007-01-16       Impact factor: 4.839

Review 2.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

3.  Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory.

Authors:  Shawn M McClintock; Munro Cullum; Mustafa M Husain; A John Rush; Rebecca G Knapp; Martina Mueller; Georgios Petrides; Shirlene Sampson; Charles H Kellner
Journal:  CNS Spectr       Date:  2010-05       Impact factor: 3.790

Review 4.  Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents.

Authors:  T Burt
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

5.  Increased cerebral blood flow associated with better response inhibition in bipolar disorder.

Authors:  Sheena I Dev; Benjamin S McKenna; Ashley N Sutherland; David D Shin; Thomas T Liu; Christina E Wierenga; Lisa T Eyler
Journal:  J Int Neuropsychol Soc       Date:  2015-03-16       Impact factor: 2.892

Review 6.  Update on the Epidemiology, Diagnosis, and Treatment of Mania in Older-Age Bipolar Disorder.

Authors:  Peijun Chen; Annemiek Dols; Soham Rej; Martha Sajatovic
Journal:  Curr Psychiatry Rep       Date:  2017-08       Impact factor: 5.285

7.  Executive dysfunction in elderly bipolar manic patients.

Authors:  Faith M Gunning-Dixon; Christopher F Murphy; George S Alexopoulos; Magdalena Majcher-Tascio; Robert C Young
Journal:  Am J Geriatr Psychiatry       Date:  2008-06       Impact factor: 4.105

8.  The neurocognitive functioning in bipolar disorder: a systematic review of data.

Authors:  Eirini Tsitsipa; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-12-01       Impact factor: 3.455

9.  Pramipexole to Improve Cognition in Bipolar Disorder: A Randomized Controlled Trial.

Authors:  Anna R Van Meter; M Mercedes Perez-Rodriguez; Raphael J Braga; Megan Shanahan; Lauren Hanna; Anil K Malhotra; Katherine E Burdick
Journal:  J Clin Psychopharmacol       Date:  2021 Jul-Aug 01       Impact factor: 3.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.